Congratulations to our PINALAPIT Study Community Advisory Board (CAB)!

The #PINALAPITStudy explores delivering twice-yearly injectable #PrEP (#lenacapavir) alongside oral PrEP across community and public health sites in the Philippines.
From 51 expressions of interest for the PINALAPIT Study CAB, we shortlisted 15 applicants for our interviews. Nine community leaders and advocates showed such strong commitment that we had to accommodate them all, expanding from just seven seats initially, to these nine leaders to join the board.
We look forward to working with our Community Advisory Board to further injectable PrEP (lenacapavir) and HIV healthcare in the country.
Thank you from all of us at SHIP! ![]()

